| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 924 | 2018 |
| Cryoablation or drug therapy for initial treatment of atrial fibrillation JG Andrade, GA Wells, MW Deyell, M Bennett, V Essebag, J Champagne, ... New England Journal of Medicine 384 (4), 305-315, 2021 | 545 | 2021 |
| Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function MS Chen, NF Marrouche, Y Khaykin, AM Gillinov, O Wazni, DO Martin, ... Journal of the American College of Cardiology 43 (6), 1004-1009, 2004 | 470 | 2004 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 399 | 2018 |
| Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies CS Elayi, A Verma, L Di Biase, CK Ching, D Patel, C Barrett, D Martin, ... Heart rhythm 5 (12), 1658-1664, 2008 | 382 | 2008 |
| Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic … L Di Biase, JD Burkhardt, P Mohanty, J Sanchez, R Horton, ... Circulation 121 (23), 2550-2556, 2010 | 351 | 2010 |
| Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study A Verma, J Champagne, J Sapp, V Essebag, P Novak, A Skanes, ... JAMA internal medicine 173 (2), 149-156, 2013 | 340 | 2013 |
| Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study M Bhargava, L Di Biase, P Mohanty, S Prasad, DO Martin, ... Heart rhythm 6 (10), 1403-1412, 2009 | 340 | 2009 |
| Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial A Verma, R Mantovan, L Macle, G De Martino, J Chen, CA Morillo, ... European heart journal 31 (11), 1344-1356, 2010 | 328 | 2010 |
| Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and … R Bai, L Di Biase, K Shivkumar, P Mohanty, R Tung, P Santangeli, ... Circulation: Arrhythmia and Electrophysiology 4 (4), 478-485, 2011 | 265 | 2011 |
| Evaluation of early complications related to de novo cardioverter defibrillator implantation: insights from the Ontario ICD database DS Lee, AD Krahn, JS Healey, D Birnie, E Crystal, P Dorian, CS Simpson, ... Journal of the American College of Cardiology 55 (8), 774-782, 2010 | 259 | 2010 |
| Delayed lead perforation: a disturbing trend MN Khan, G Joseph, Y Khaykin, KM Ziada, BL Wilkoff Pacing and clinical electrophysiology 28 (3), 251-253, 2005 | 251 | 2005 |
| A prospective, multicenter evaluation of ablating complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an automated mapping algorithm: acute … A Verma, P Novak, L Macle, B Whaley, M Beardsall, Z Wulffhart, ... Heart rhythm 5 (2), 198-205, 2008 | 213 | 2008 |
| Impact of coronary sinus lead position on biventricular pacing: Mortality and echocardiographic evaluation during long‐term follow‐up A Rossillo, A Verma, EB Saad, A Corrado, G Gasparini, NF Marrouche, ... Journal of cardiovascular electrophysiology 15 (10), 1120-1125, 2004 | 200 | 2004 |
| Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION Study V Essebag, A Verma, JS Healey, AD Krahn, E Kalfon, B Coutu, ... Journal of the American College of Cardiology 67 (11), 1300-1308, 2016 | 198 | 2016 |
| Complications associated with defibrillation threshold testing: the Canadian experience D Birnie, S Tung, C Simpson, E Crystal, D Exner, FAA Paredes, A Krahn, ... Heart rhythm 5 (3), 387-390, 2008 | 197 | 2008 |
| Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation CS Elayi, L Di Biase, C Barrett, CK Ching, M Al Aly, M Lucciola, R Bai, ... Heart rhythm 7 (9), 1216-1223, 2010 | 165 | 2010 |
| Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques L Di Biase, CS Elayi, TS Fahmy, DO Martin, CK Ching, C Barrett, R Bai, ... Circulation: Arrhythmia and Electrophysiology 2 (2), 113-119, 2009 | 163 | 2009 |
| Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database DR MacFadden, E Crystal, AD Krahn, I Mangat, JS Healey, P Dorian, ... Annals of internal medicine 156 (3), 195-203, 2012 | 160 | 2012 |
| Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database AD Krahn, DS Lee, D Birnie, JS Healey, E Crystal, P Dorian, CS Simpson, ... Circulation: Arrhythmia and Electrophysiology 4 (2), 136-142, 2011 | 154 | 2011 |
